Literature DB >> 9266955

Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia.

M Briz1, R Forés, C Regidor, M J Busto, S Ramon y Cajal, R Cabrera, J L Díez, I Sanjuán, M N Fernández.   

Abstract

Epstein-Barr virus associated lymphoproliferative disease after autologous bone marrow transplantation (ABMT) has rarely been reported. We report a case of B-cell lymphoma following ABMT for T-acute lymphoblastic leukaemia; bone marrow was purged in vitro with monoclonal antibodies to remove T cells. Immunoglobulin and T-cell receptor gene rearrangement studies were used to demonstrate clonality and to show that this patient developed a second neoplasm after ABMT. EBV proteins and genome (type A) were present in post-transplantation lymphoma, suggesting a causative role in its development.

Entities:  

Mesh:

Year:  1997        PMID: 9266955     DOI: 10.1046/j.1365-2141.1997.2153034.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

2.  Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy.

Authors:  George M Viola; Youli Zu; Kelty R Baker; Saima Aslam
Journal:  Med Oncol       Date:  2010-08-03       Impact factor: 3.064

3.  Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.

Authors:  Richard A Nash; Roger Dansey; Jan Storek; George E Georges; James D Bowen; Leona A Holmberg; George H Kraft; Maureen D Mayes; Kevin T McDonagh; Chien-Shing Chen; John Dipersio; C Fred Lemaistre; Steven Pavletic; Keith M Sullivan; Julie Sunderhaus; Daniel E Furst; Peter A McSweeney
Journal:  Biol Blood Marrow Transplant       Date:  2003-09       Impact factor: 5.742

4.  Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma.

Authors:  Alberto Zambelli; Daniele Lilleri; Fausto Baldanti; Mario Scelsi; Laura Villani; Gian Antonio Da Prada
Journal:  BMC Cancer       Date:  2005-08-23       Impact factor: 4.430

5.  An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma.

Authors:  J L Powell; N J Bunin; C Callahan; R Aplenc; G Griffin; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2004-03       Impact factor: 5.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.